🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT03211624
Active, not recruiting Observational

Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome

NCT03211624 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2017-05-01
Last updated
2025-04-06

Condition(s) studied

Cushing Syndrome

Study summary

This is a prospective, multi-center, case-control study where neurocognitive function will be evaluated in 36 patients with Cushing syndrome (CS) and 36 controls matched for age, gender and education.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion criteria: * Male and female patients with Cushing syndrome (CS) caused by ACTH-producing pituitary adenoma or cortisol producing adrenal adenoma * Age between 18 and 65 years Exclusion criteria * CS caused by ectopic ACTH producing tumours * CS caused by adrenocortical carcinoma * Pseudo CS * Subclinical CS * Exogenous CS * Previous history of major psychiatric disorder (not related to CS) * Neurological disorders affecting the central nervous system * High alcohol consumption (more than 14 units of alcohol per week) * Active malignancy or any treatment for malignancy during the last 2 years * Heart failure (NYHC II-IV) * Severe respiratory insufficiency * Severely impaired hepatic function (alanine transaminase and/or aspartate transaminase concentrations two times the upper limit of normal or above) * Severely impaired renal function (serum- creatinine \>150 µmol/L or glomerular filtration rate \<45 ml/min) * Pregnancy or breast feeding * Any other illness that significantly affects the patients cognitive function according to the investigators opinion * Contraindication for MRI (Presence of medical implants, metal in the body, claustrophobia)

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Dept of Medicine, Division of Endocrinology, and Center for Endocrine Tumors, Leiden University Medical Center Leiden Netherlands
Dept of Endocrinology, Hospital Sant Pau Barcelona Spain
Sahlgrenska University Hospital Gothenburg Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03211624 on ClinicalTrials.gov ↗ ← All trials in Spain